Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-07

Clinical Trial Update: Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing pyronaridine-artesunate to artemether-lumefantrine for malaria shows efficacy and safety data from completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)
  • Pyronaridine-artesunate (pyronaridine/artesunate)

Snippet

Sponsor: University of Ibadan | Conditions: Malaria Fever, Plasmodium Falciparum Malaria | Phase 2, Phase 3 | Status: COMPLETED